Cardiovascular Effects of Incretin-Based Therapies.
Farmington, United States. In Annu Rev Med, Feb 2016
This article reviews the most recent CV outcome trials of the DPP-4 inhibitors (SAVOR-TIMI 53, EXAMINE, and TECOS) as evidence that the incretin-based therapies have acceptable CV safety profiles for patients with T2DM.
Decapentaplegic and growth control in the developing Drosophila wing.
Kansas City, United States. In Nature, Dec 2015
As a central model for morphogen action during animal development, the bone morphogenetic protein 2/4 (BMP2/4)-like ligand Decapentaplegic (Dpp) is proposed to form a long-range signalling gradient that directs both growth and pattern formation during Drosophila wing disc development.